Nicholas A Saccomano, President and CEO at OnKure Therapeutics, sold OKUR on Jun 22, 2026

Data as of Oct 27

▼ SELL$37886 shares at $4.40Nicholas A Saccomano President and CEOOKUR OnKure Therapeutics, Inc.

Watch OKUR

Traded: Jun 22, 2026
Disclosed: Jun 24, 2026
Filed: 2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

OKURSimilar stocks (S&P 500 (SPY)), rebased to OKUR's price on the disclosure day

OKUR since disclosure

−40.2%

after the sale

Similar stocks (SPY) since disclosure

+5.0%

S&P 500 (SPY)

Change in closing price from Jun 24, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on OKUR →